^
    Back
    Association details:
    Biomarker:DIRAS3 overexpression
    Cancer:Cervical Cancer
    Drug:paclitaxel (Tubulin inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Drug Dev Res
    Title:

    Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy

    Published date:
    06/30/2021
    Excerpt:
    Cervical cancer (CC)...overexpression of ARHI can increase the sensitivity of CC to paclitaxel through promoting apoptosis…
    DOI:
    10.1002/ddr.21852